Lv5
1600 积分 2020-12-24 加入
Targeting ESE3/EHF With Nifurtimox Inhibits CXCR2+ Neutrophil Infiltration and Overcomes Pancreatic Cancer Resistance to Chemotherapy and Immunotherapy
1天前
已完结
Lipotoxicity and the gut-liver axis in NASH pathogenesis
21天前
已完结
Triggering and resolution of inflammation in NASH
21天前
已完结
The role of RNA binding proteins in hepatocellular carcinoma
21天前
已完结
N6-methyladenosine RNA modification in nonalcoholic fatty liver disease
21天前
已完结
Alternative splicing: a bridge connecting NAFLD and HCC
21天前
已完结
USP25 directly interacts with and deubiquitinates PPARα to increase PPARα stability in hepatocytes and attenuate high-fat diet-induced MASLD in mice
21天前
已完结
Hepatic TM6SF2 activates antitumour immunity to suppress metabolic dysfunction-associated steatotic liver disease-related hepatocellular carcinoma and boosts immunotherapy
21天前
已完结
Hepatic TM6SF2 activates antitumour immunity to suppress metabolic dysfunction-associated steatotic liver disease-related hepatocellular carcinoma and boosts immunotherapy
21天前
已完结
Metabolic Dysfunction–Associated Steatotic Liver Disease
21天前
已完结
皖公网安备34019202002308
